Senior insider sale
TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$633.6K
10K shares
What this filing means
LYONS GARY A plans to sell 10K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $633.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/18/2026ACC: 0001950047-26-008327
10K
Shares to sell
$633.6K
Approx. market value
5K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
8/18/2026
5KTotal acquired5K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/18/2026 | Exercise of Stock Options Cash | 5K | — |
| Total | 5K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
5K
Market value
$316.0K
8/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
5K
Market value
$317.6K
8/18/2026
Total
Units
10K
Value
$633.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/17/2026 | 5K | $316.0K | — | Completed |
| Planned — Approximate Date | ||||
8/18/2026 | 5K | $317.6K | NASDAQ | Planned |
| Total | 10K | $633.6K | ||